Vivos Therapeutics VVOS
NASDAQ VVOS
$0.28 +0.00 (+1.79%)
At close: Aug 20, 2026 · 1:15 PM UTC

Vivos Therapeutics (VVOS) Preferred Dividend Payments (2020)

Vivos Therapeutics (VVOS) posted quarterly Preferred Dividend Payments of $1.6 million for Q4 2020, up 533.2% quarter-over-quarter from $250000.0 in Q3 2020.

Vivos Therapeutics (VVOS) Preferred Dividend Payments (2020) Analysis & Trends

Vivos Therapeutics (VVOS) has reported Preferred Dividend Payments for 1 consecutive years, with $1.6 million the latest figure, recorded in Q4 2020.

  • In Q4 2020, Preferred Dividend Payments changed N/A year-over-year to $1.6 million; the TTM figure through Dec 2020 stood at $2.3 million (changed N/A YoY), while the FY2020 annual figure was $2.3 million, up 133.3% from the prior year.
  • Preferred Dividend Payments rose to $1.6 million in Q4 2020 per VVOS's latest filing, from $250000.0 in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $1.6 million in Q4 2020 and bottomed at $250000.0 in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Abbott Laboratories 198.95 Bn 193.35 Bn 7.27 Bn -
2 Stryker 128.10 Bn 124.63 Bn 4.50 Bn -
3 Medtronic 118.91 Bn 109.69 Bn 6.41 Bn -
4 Boston Scientific 73.43 Bn 72.89 Bn 3.85 Bn -
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn -
6 Dexcom 34.52 Bn 32.58 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.94 Bn 31.83 Bn 2.18 Bn -
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn -
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn -
10 Vivos Therapeutics 4.96 Mn 3.16 Mn 2.95 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2020 1.58 Mn
Sep 30, 2020 250,000.00
Jun 30, 2020 250,000.00
Mar 31, 2020 250,000.00